Updates in Therapy for Advanced Melanoma

Cancers
Bhavana P Singh, April K S Salama

Abstract

Cutaneous melanoma is one of the most aggressive forms of skin cancer, and is correlated with a large proportion of skin cancer-related deaths. Therapy for cutaneous melanoma has advanced greatly through careful identification of therapeutic targets and the development of novel immunotherapeutic approaches. The identification of BRAF as well as other driver mutations, have allowed for a specialized approach to treatment. In addition, immune checkpoint inhibition has dramatically changed the treatment landscape over the past 5-10 years. The successful targeting of CTLA-4, as well as PD-1/PD-L1, has been translated into meaningful clinical benefit for patients, with multiple other potential agents in development. Systemic therapy for cutaneous melanoma is becoming more nuanced and often takes a multifaceted strategy. This review aims to discuss the benefits and limitations of current therapies in systemic melanoma treatment as well as areas of future development.

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R MiddletonN Thatcher
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 13, 2002·Expert Review of Anticancer Therapy·S J Danson, M R Middleton
Aug 2, 2002·Cancer Cell·Pamela M Pollock, Paul S Meltzer
Nov 26, 2002·Nature Genetics·Pamela M PollockPaul S Meltzer
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John A CurtinBoris C Bastian
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raanan BergerArnon Nagler
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carol BeadlingChristopher L Corless
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael A CurranJames P Allison
Apr 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michal J BesserJacob Schachter
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Apr 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven A RosenbergMark E Dudley
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Richard D CarvajalGary K Schwartz
Jun 22, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jun GuoShukui Qin
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Mar 23, 2012·Nature Reviews. Immunology·Nicholas P RestifoSteven A Rosenberg
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Oct 2, 2012·The New England Journal of Medicine·Keith T FlahertyJeffrey Weber
Oct 3, 2012·The American Journal of Surgical Pathology·Georgina V LongRichard A Scolyer
Dec 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chengwen LiuPatrick Hwu
Jan 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dennie T FrederickJennifer A Wargo
Feb 5, 2013·Journal of Immunotherapy·Richard A MorganSteven A Rosenberg
Apr 5, 2013·The New England Journal of Medicine·Antoni RibasJedd Wolchok
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jun 19, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·April K S Salama, Keith T Flaherty
Jun 19, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Stephen HodiDavid E Fisher
Aug 27, 2013·Current Oncology Reports·April K S Salama, Kevin B Kim
Oct 1, 2013·Cancer Control : Journal of the Moffitt Cancer Center·Giao Q Phan, Steven A Rosenberg
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 28, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helen RizosGeorgina V Long
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Jun 12, 2014·Journal of Cutaneous Pathology·Michelle V PearlsteinNancy E Thomas
Jun 12, 2014·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jing LuScott A Soefje
Jun 19, 2014·JAMA : the Journal of the American Medical Association·Richard D CarvajalGary K Schwartz
Jul 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yong-Chen LuPaul F Robbins

❮ Previous
Next ❯

Citations

Jul 10, 2016·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·T R GlowkaD Pantelis
Nov 12, 2016·Frontiers in Endocrinology·Monica MarzagalliPatrizia Limonta
Mar 28, 2018·Cell Proliferation·Xin YuWilliam Kk Wu
May 24, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I C Glitza OlivaH Tawbi
Aug 18, 2016·Oncotarget·Jinhua WangGuanhua Du
Feb 21, 2019·BMC Pregnancy and Childbirth·Matyas MeggyesLaszlo Szereday
Feb 26, 2019·Frontiers in Pharmacology·Giuseppe ErcolanoAngela Ianaro
Jun 30, 2019·Cancers·Monique K van der KooijEllen Kapiteijn
Jun 16, 2017·Journal of Cancer Research and Clinical Oncology·C BrüggemannL Heinzerling
Jun 4, 2021·Molecular Oncology·Barbara MonticoElisabetta Fratta
Jan 20, 2021·ACS Biomaterials Science & Engineering·Vijay Sagar MadamsettySudip Mukherjee
Oct 14, 2020·European Journal of Pharmacology·Bharath Singh PadyaSrinivas Mutalik

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02155647
NCT01968109
NCT02263508
NCT02320058
NCT02089685
NCT01740297
NCT02224781
NCT01940809
NCT02130466
NCT01656642

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

© 2022 Meta ULC. All rights reserved